Nonimmunologic causes of late renal graft lossBIA, M. J.Kidney international. 1995, Vol 47, Num 5, pp 1470-1480, issn 0085-2538Conference Paper

Evidence that calcium channel blockade prevents cyclosporine-induced exacerbation of renal ischemic injuryBIA, M. J; TYLER, K.Transplantation. 1991, Vol 51, Num 2, pp 293-295, issn 0041-1337, 3 p.Conference Paper

Treatment of sarcoidosis-associated hypercalcemia with ketoconazoleBIA, M. J; INSOGNA, K.American journal of kidney diseases. 1991, Vol 18, Num 6, pp 702-705, issn 0272-6386Article

The evaluation and selection of living kidney donorsKASISKE, B. L; BIA, M. J.American journal of kidney diseases. 1995, Vol 26, Num 2, pp 387-398, issn 0272-6386Article

Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporterSIMON, D. B; NELSON-WILLIAMS, C; GAINZA, F. J et al.Nature genetics. 1996, Vol 12, Num 1, pp 24-30, issn 1061-4036Article

Effects of cyclosporine on the pathogenesis of primary cytomegalovirus infection in the guinea pigBIA, F. J; LUCIA, H. L; BIA, M. J et al.Intervirology. 1985, Vol 24, Num 3, pp 154-165, issn 0300-5526Article

Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19⁺ B lymphocytesMORRISSEY, P. E; LORBER, K. M; MARCARELLI, M et al.Transplantation. 1995, Vol 59, Num 4, pp 637-640, issn 0041-1337Conference Paper

Adrenergic modulation of potassium metabolism in uremiaCASTELLINO, P; BIA, M. J; DEFRONZO, R. A et al.Kidney international. 1990, Vol 37, Num 2, pp 793-798, issn 0085-2538Article

The effect of dexamethasone on renal potassium excretion and acute potassium toleranceBIA, M. J; TYLER, K; DEFRONZO, R et al.Endocrinology (Philadelphia). 1983, Vol 113, Num 5, pp 1690-1696, issn 0013-7227Article

Effects of H₂-receptor antagonists on renal function in cyclosporine-treated renal transplant patientsPACHON, J; LORBER, M. I; BIA, M. J et al.Transplantation. 1989, Vol 47, Num 2, pp 254-259, issn 0041-1337, 6 p.Conference Paper

Body size mismatch between donor and recipient and the development of chronic rejection in renal transplantationLEE, L. S; AUERSVALD, L. A; CLAUS, E. B et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, issn 0041-1345, p. 111Conference Paper

Unusual causes of increased vascular impedance in renal transplants: duplex Doppler evaluationWARSHAUER, D. M; TAYLOR, K. J. W; BIA, M. J et al.Radiology. 1988, Vol 169, Num 2, pp 367-370, issn 0033-8419Article

Postbiopsy renal allograft arteriovenous fistula: therapeutic embolizationMORSE, S. S; SNIDERMAN, K. W; STRAUSS, E. B et al.Urologic radiology. 1985, Vol 7, Num 3, pp 161-164, issn 0171-1091Article

Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantationFORMICA, R. N; LORBER, K. M; FRIEDMAN, A. L et al.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 95-98, issn 0041-1345, 4 p., SUPConference Paper

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapyDARENKOV, I. A; MARCARELLI, M. A; BASADONNA, G. P et al.Transplantation. 1997, Vol 64, Num 6, pp 848-852, issn 0041-1337Conference Paper

Must living renal donors be hospitalized overnight prior to surgery ?FRIEDMAN, A. L; GOKER, O; DENNIS, M. J et al.Clinical transplantation. 1996, Vol 10, Num 5, pp 444-446, issn 0902-0063Article

The evolving experience using everolimus in clinical transplantationFORMICA, R. N; LORBER, K. M; FRIEDMAN, A. L et al.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 495S-499S, issn 0041-1345, SUPArticle

Evaluation of living renal donors : the current practice of US transplant centersBIA, M. J; RAMOS, E. L; DANOVITCH, G. M et al.Transplantation. 1995, Vol 60, Num 4, pp 322-327, issn 0041-1337Article

Are calcium channel blockers protective against first-dose reactions to OKT3 ?RICHARD, E. A; LORBER, M. I; MARKS, W. H et al.Transplantation. 1992, Vol 54, Num 2, pp 372-374, issn 0041-1337Article

Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysisBIA, M. J; COOPER, K; SCHNALL, S et al.Kidney international. 1989, Vol 36, Num 5, pp 852-858, issn 0085-2538Article

Microalbuminuria and hypertension in long-term renal donorsWATNICK, T. J; JENKINS, R. R; RACKOFF, P et al.Transplantation. 1988, Vol 45, Num 1, pp 59-65, issn 0041-1337Conference Paper

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant periodFORMICA, R. N; FRIEDMAN, A. L; LORBER, M. I et al.Transplantation proceedings. 2004, Vol 36, Num 9, pp 2675-2678, issn 0041-1345, 4 p.Article

The evolving role of TOR inhibitors for individualizing posttransplant immunosuppressionLORBER, M. I; BASADONNA, G. P; FRIEDMAN, A. L et al.Transplantation proceedings. 2001, Vol 33, Num 7-8, pp 3075-3077, issn 0041-1345Article

Enalapril treatment of posttransplant erythrocytosis : efficacy independent of circulating erythropoietin levelsPERAZELLA, M; MCPHEDRAN, P; KLIGER, A et al.American journal of kidney diseases. 1995, Vol 26, Num 3, pp 495-500, issn 0272-6386Article

Donor-specific transfusions before transplantation: a comparison of results in children and adults at the same institutionBOVE, S; GAUDIO, K; SIEGEL, N et al.Transplantation. 1988, Vol 45, Num 1, pp 224-225, issn 0041-1337Conference Paper